The Effect of COVID-19 on Type 1 Diabetes Occurrence among Children and Adolescents: A Multicenter Prospective

Noah Gruber1,2, Liat Brand1,2, Ehud Barhod3

  • 1Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.

Pediatric Diabetes
|April 30, 2025
PubMed

Insights

This study found no link between SARS-CoV-2 infection and new-onset type 1 diabetes (T1D) in children. Further research is needed to understand long-term effects of the pandemic on pediatric T1D incidence.

Area of Science:

  • Pediatric Endocrinology
  • Infectious Diseases
  • Immunology

Background:

  • The relationship between SARS-CoV-2 infection and type 1 diabetes (T1D) in children remains unclear.
  • Investigating potential links between viral infections and autoimmune diseases like T1D is crucial.

Purpose of the Study:

  • To determine if there is an association between SARS-CoV-2 infection seroprevalence and the occurrence of T1D in pediatric populations.
  • To analyze distinct anti-SARS-CoV-2 antibody responses in children with new-onset T1D compared to a control group.

Main Methods:

  • A multicenter prospective observational cohort study involving children with new-onset T1D and a control group (1:3 ratio).
  • Assessment of anti-SARS-CoV-2 antibodies (anti-S, anti-N, neutralizing antibodies) in both groups.
  • Comparison of antibody seroprevalence and association with glycemic parameters and diabetic ketoacidosis (DKA).

Main Results:

  • No increased seroprevalence of anti-SARS-CoV-2 antibodies was found in children with new-onset T1D compared to controls.
  • A higher anti-S seroprevalence was observed in T1D patients without DKA, but this was not statistically significant after adjusting for vaccination status.
  • No significant differences in anti-N or neutralizing antibodies were found between DKA and non-DKA groups, nor were antibodies associated with glycemic parameters.

Conclusions:

  • Current findings do not support a direct association between SARS-CoV-2 infection and the incidence of T1D in children and adolescents.
  • Longitudinal epidemiological studies are recommended to evaluate potential delayed autoimmune responses and changes in T1D incidence post-pandemic.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
136
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
839
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
21